About 276,000 results
Any time 
Open links in new tab
- In a news release published Dec. 20, the FDA stated that Zepbound, part of the GLP-1 receptor agonist medicines that include Ozempic, was cleared to treat moderate to severe OSA in individuals with obesity.www.usnews.com/news/health-news/articles/2024-12-23/glp-1-zepbound-is-app…
obstructive sleep apnea, Food and Drug Administration
âś•About this result- This title and these news articles are related to your search term(s).
- Articles come from a variety of sources across the web.
- Titles are algorithmically generated based on content related to your search term(s).
FDA Approves Zepbound for Obstructive Sleep Apnea - WebMD
2 days ago · Dec. 23, 2024 -- The FDA has approved the first prescription drug, Zepbound, for treating moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Studies …
FDA approves weight-loss drug Zepbound for obstructive sleep …
4 days ago · The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound. The medicine, part of …
FDA approves weight loss drug Zepbound for sleep apnea - NBC …
4 days ago · The approval is based on two trials of men and women with obesity and moderate to severe sleep apnea. In Lilly's sleep apnea research, people who took Zepbound lost around …
FDA approves Zepbound® (tirzepatide) as the first and only …
4 days ago · About Zepbound ® (tirzepatide) injection Zepbound ® (tirzepatide) injection is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity. It is …
GLP-1 Zepbound is approved as first drug for sleep apnea
1 day ago · The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug …
- People also ask
Lilly Rises on FDA Approval of Weight-Loss Drug Zepbound for …
2 days ago · Lilly said its final trial evaluated sleep apnea and weight loss in those taking Zepbound, with some patients using a traditional "positive airway pressure" (PAP) mask while …
FDA approves weight loss drug Zepbound to treat sleep apnea : NPR
3 days ago · The AASM said patients on Zepbound should know that sustained weight loss is required for it to be effective against sleep apnea symptoms. Shots - Health News FDA …
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
4 days ago · The drug’s maker, Eli Lilly, announced that the agency authorized Zepbound for people with obesity and moderate to severe obstructive sleep apnea. Millions of Americans …
Tirzepatide reduced sleep apnea severity by up to nearly two …
INDIANAPOLIS, April 17, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results of the SURMOUNT-OSA phase 3 clinical trials that showed …
